Andrew J. Bessire - Concepedia

Author

Andrew J. Bessire

Pfizer (United States)

Also Known As

A. J. BESSIRE, Andrew Bessire, Andrew J. Bessire

Publications

312

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)

About

Andrew J. Bessire is an author at Pfizer (United States) specializing in pharmacology, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	167
2	Natural Sciences	5	5	155
3	Biochemistry	5	5	133
4	Biomolecular Engineering	1	1	21
5	Chemical Biology	1	1	21

Andrew J. Bessire

Publications

274

Citations

H-Index

Page 1

	Year	Citations
Optimization of Tubulysin Antibody–Drug Conjugates: A Case Study in Addressing ADC Metabolism L. Nathan Tumey, Carolyn A. Leverett, Beth C. Vetelino, ACS Medicinal Chemistry Letters Pharmaceutical SciencePharmaceutical ChemistryMedicinal ChemistryBioanalysisImmunochemistry	2016	70
An Analytical Method for the Analysis of Tulathromycin, an Equilibrating Triamilide, in Bovine and Porcine Plasma and Lung D.M. Galer, Scott Hessong, Brian D. Beato, Journal of Agricultural and Food Chemistry	2004	51
Determination of Antibody–Drug Conjugate Released Payload Species Using Directed in Vitro Assays and Mass Spectrometric Interrogation Andrew J. Bessire, T. Eric Ballard, Manoj B. Charati, Bioconjugate Chemistry Drug TargetVitro AssaysImmunologyBiological Mass SpectrometryBioanalysis	2016	34
Deconstruction of Activity-Dependent Covalent Modification of Heme in Human Neutrophil Myeloperoxidase by Multistage Mass Spectrometry (MS<sup>4</sup>) Kieran F. Geoghegan, Alison H. Varghese, Xidong Feng, Biochemistry Bioorganic ChemistryBiological Mass SpectrometryChemical BiologyRedox BiologyOxidative Stress	2012	21
A rapid and specific derivatization procedure to identify acyl‐glucuronides by mass spectrometry Alfin D. N. Vaz, Wei Wei Wang, Andrew J. Bessire, Rapid Communications in Mass Spectrometry	2010	21
Use of high‐resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples Michael Furlong, Andrew J. Bessire, Wei Song, Rapid Communications in Mass Spectrometry Metabolite InterferenceBiological Mass SpectrometryMetabolomic ProfilingHigh‐resolution Mass SpectrometryPotential Interferences	2010	17
Development of Fluorophore-Labeled Thailanstatin Antibody-Drug Conjugates for Cellular Trafficking Studies Chethana Kulkarni, James E. Finley, Andrew J. Bessire, Bioconjugate Chemistry	2017	14
Dirlotapide as a model substrate to refine structure-based drug design strategies on CYP3A4-catalyzed metabolism Hao Sun, Andrew J. Bessire, Alfin D. N. Vaz Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMolecular PharmacologyMedicinal ChemistryCyp3a4-catalyzed MetabolismBiochemistry	2011	13
Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide Ralph P. Robinson, Jeremy A. Bartlett, Peter Bertinato, Bioorganic & Medicinal Chemistry Letters Metabolic SyndromeBiochemistryMedicineMetabolomic ProfilingPharmacotherapy	2011	12
A tag‐free collisionally induced fragmentation approach to detect drug‐adducted proteins by mass spectrometry T. Eric Ballard, Upendra P. Dahal, Andrew J. Bessire, Rapid Communications in Mass Spectrometry	2015	11

Page 1